Labocanna Spolka Akcyjna Logo

Labocanna Spolka Akcyjna

Cultivates, produces, and distributes hemp products for food and medical use.

LCN | WAR

Overview

Corporate Details

ISIN(s):
PLCCTLS00017 (+1 more)
LEI:
259400GAPNZTGIR9PK55
Country:
Poland
Address:
KOSZALIN MIESZKA I 49, 75-129 KOSZALIN

Description

Labocanna Spolka Akcyjna is a company engaged in the cultivation, production, and distribution of hemp products. Its offerings include food and medical hemp-derived items. The company's primary strategic goal is to launch the production of medical marijuana for patients and clinical use, with a focus on indoor cultivation methods. Labocanna is pursuing collaborations with research institutes to produce pharmaceutical raw materials and is actively developing new compounds and mixtures based on cannabinoids such as CBD, CBG, and CBC. The company plans to manage 500 hectares of cultivation fields through acquisitions and contracting.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-02-09 17:33
Zawarcie przedwstępnej umowy na import marihuany medycznej - Content (PL)
Polish 2.3 KB
2024-02-09 08:40
Rozwiązanie Umowy Inwestycyjnej w sprawie połączenia ze spółką Foxbuy.com S.A. …
Polish 806 bytes
2024-01-24 17:56
Lista akcjonariuszy, którzy wzięli udział w Walnym Zgromadzeniu oraz mieli co n…
Polish 810 bytes
2024-01-18 08:46
Otrzymanie pisma z Instytutu Weterynaryjnego - Państwowego Instytutu Badawczego…
Polish 874 bytes
2024-01-02 17:24
Wygaśnięcie umowy o zachowaniu poufności - Content (PL)
Polish 654 bytes
2023-12-28 17:28
Formularz dla pełnomocnika
Polish 133.8 KB
2023-12-28 17:28
Proponowane zmiany statutu Labocanna S.A.
Polish 183.6 KB
2023-12-28 17:28
Projekty uchwał na NWZA Labocanna S.A.
Polish 221.4 KB
2023-12-28 17:28
Ogłoszenie o NWZA Labocanna S.A.
Polish 99.3 KB
2023-12-28 17:28
ogłoszenie o zwołaniu NWZ na dzień 24 stycznia 2024 r. wraz z projektami uchwał…
Polish 469 bytes
2023-12-28 16:49
Lista akcjonariuszy, którzy wzięli udział w Walnym Zgromadzeniu oraz mieli co n…
Polish 603 bytes
2023-12-20 18:02
Założenie spółki zależnej - Content (PL)
Polish 1.0 KB
2023-12-01 15:37
Formularz dla pełnomocnika na NWZA
Polish 132.6 KB
2023-12-01 15:37
Proponowane zmiany statutu na NWZA
Polish 204.9 KB
2023-12-01 15:37
Projekty uchwła na NWZA
Polish 246.8 KB

Automate Your Workflow. Get a real-time feed of all Labocanna Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Labocanna Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Labocanna Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ALNYLAM PHARMACEUTICALS, INC. Logo
A biopharmaceutical company developing RNA interference (RNAi) therapeutics.
United States of America
ALNY
Alpha Cognition Inc. Logo
A biopharmaceutical company developing treatments for neurodegenerative diseases.
United States of America
ACOG
Alpha Teknova, Inc. Logo
Manufacturer of critical reagents for the life sciences industry.
United States of America
TKNO
ALTERITY THERAPEUTICS LTD Logo
A clinical-stage biotech developing novel treatments for neurodegenerative diseases.
United States of America
ATHE
Altimmune, Inc. Logo
Clinical-stage biopharma developing peptide therapeutics for obesity and liver diseases.
United States of America
ALT
Alto Neuroscience, Inc. Logo
Develops precision medicines for neuropsychiatric conditions using patient biology.
United States of America
ANRO
ALUMIS INC. Logo
Clinical-stage biopharma developing precision medicines for autoimmune diseases.
United States of America
ALMS
Alvotech Holdings S.A Logo
A biotechnology company developing and manufacturing biosimilar medicines worldwide.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage immuno-oncology company developing therapies to combat cancer.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Develops treatments for neurodegenerative diseases and psychiatric disorders.
United States of America
ALZN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.